A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy (2019)

Peer-Reviewed Study · Molassiotis A, Suen LKP, Cheng HL, Mok TSK, Lee SCY, Wang CH, Lee P, Leung H, Chan V, Lau TKH, Yeo W · January 2019

Molassiotis A et al., 2019-01: Assessor-blinded randomised trial in 87 patients comparing eight weeks of acupuncture with a wait-list control: significant improvements in pain, neurological assessment and quality-of-life domains, sustained to 20 weeks.

Acupuncture is an effective intervention for treating chemotherapy-induced peripheral neuropathy and improving patients' quality of life and experience with neurotoxicity-related symptoms with longer term effects evident.

Abstract, Results

Molassiotis A et al., 2019-01: Assessor-blinded randomised trial in 87 patients comparing eight weeks of acupuncture with a wait-list control: significant improvements in pain, neurological assessment and quality-of-life domains, sustained to 20 weeks. Study type: randomized trial.